Comment from Accenture
AnonymousSupportBusiness
Summary: Dinesh Agaram, representing Accenture, supports the draft guidance and the Roadmap to Reducing Animal Testing. The commenter proposes specific drafting clarifications to define three evidentiary states for New Approach Methodologies (NAMs), allow for prospectively generated portfolio evidence, and scale validation expectations based on the regulatory consequences of the decisions.
Dear Members of the Dockets Management Staff:
We support the direction set by the March 2026 draft guidance and the April 2025 Roadmap to Reducing Animal Testing.
We write with three specific drafting clarifications that would sharpen the guidance within its stated scope, and one implementation note aligned with the Roadmap. Please read full comment in attached PDF.
Thank you
Dinesh Agaram